The independent platform for news, articles and advice for professionals in laboratory medicine

MHRA updates timeframe for CE-marked medical devices

Following the legislation introduced during May to extend the acceptance of CE-marked medical devices on the Great Britain market, the MHRA has further updated its future plans

Now accepted into law, the new regulations (The Medical Devices (Amendment) (Great Britain) Regulations 2023) enable CE-marked medical devices to be accepted in Great Britain for defined periods beyond 30 June 2023.

This measure aims to support the ongoing and safe supply of medical devices within Great Britain and facilitate a smooth transition towards a future strengthened regulatory framework for medical devices.

It is the first statutory instrument in a series that are planned to implement the strengthened framework. Next in the series, the MHRA intends to lay a statutory instrument later this year that will put in place enhanced post-market surveillance requirements.

Core aspects of the future framework for medical devices are intended to apply from 1 July 2025. This timeline is subject to ongoing review as the MHRA continues to monitor feedback from external stakeholders, for instance on the capacity of conformity assessment bodies.

The MHRA guidance has been updated to reflect these changes to the acceptance of CE-marked medical devices in Great Britain. This includes an infographic of the timelines for acceptance of CE-marked medical devices on the GB market, which is available here.

These measures do not affect requirements for placing UKCA marked medical devices on the Great Britain market. The MHRA’s intended position on transitional arrangements for such devices is in Chapter 15 of the response to the consultation on future regulation of medical devices in the UK. The MHRA will continue to work with industry, trade associations and the wider medical devices community to support the effective development of the new regime.

 

Upcoming Events

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

Interpreting Reports: UK NEQAS Haematology

ONLINE
21st March 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

Interpreting Reports: UK NEQAS Haematology

ONLINE
21st March 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025